The New Female Viagra – Vyleesi

Sex is great, but let’s face it, sometimes we’re not always in the mood to try a new sex position or any sex position for that matter. Our sex drive can dip allowing us to avoid intimacy.  It’s normal, especially for women. However, the FDA have recently approved a new drug in the US which is set to be released in September called Vyleesi.

The drug has been hailed as the new “Viagra for women”. But is it really? Of course, Viagra is known for helping men maintain an erection during sex, but Vyleesi is a desire drug, used to help boost the libido of women.

Bremelanotide which is Vyleesi’s chemically known name is meant to activate melanocortin receptors in the brain which has been linked to sexual desire. Palatin Technologies and licensed to Amag Pharmaceuticals are behind the development of the newly designed drug aimed at premenopausal women with hypoactive sexual desire disorder (HSDD)

In fact, in 2015 a similar drug was released called Addyi but did poorly in sales after it was given terrible reviews by scientists. Addyi is meant to be taken once every day, which can be pretty intense.

Vyleesi is slightly different and maybe even an upgrade, as you simply have to inject yourself on your thigh or stomach 45 minutes before sexual intimacy takes place. It can also be taken with alcohol, unlike Addyi, which is a bonus. The FDA does advise to only take it once in 24 hours and only 8 shots in a month.

Is this a celebration for sexual wellness and should it really be compared to Viagra? Perhaps, if it was an injection for vaginismus maybe. But a libidio is changed due to the circumstances you might be facing. This could be work related issues, stress, difficulties in your relationships etc.

Should we rely on a drug or does it depend on its usage?